An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675

The aim of the phase 1, single-center, randomized, active-controlled study in healthy volunteers reported in this paper was to investigate the pharmacodynamic effects and safety of different dosing regimens of RDX7675 in humans.

Request a copy of our scientific poster titled, 'An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675'.